semaglutide weight loss south congress Medicare's new GLP-1 Bridge program will offer popular medications at a reduced $50 monthly rate for eligible beneficiaries, making these treatments more affordable and accessible. Read more on this story Medicare will now cover weight

Advances in the preclinical study of ischemic stroke

Glomerular function Acromegalic patients show glomerular hyperfiltration characterized by an approx

July 10, 2026 Single Use Single-use tech: From convenience to core biopharma strategy July 7, 2026 Automation & Control Eli Lilly taps AI, digital twin technology to boost manufacturing capacity June 11, 2026 Scale-Up US pharma manufacturing set for steady job growth through 2034: report June 5, 2026 Scale-Up Pharma shift to biologics, away from small molecules impacts manufacturing June 1, 2026 Continuous Trumps FY27 budget proposes $325M increase for domestic pharma manufacturing April 17, 2026 Scale-Up US biomanufacturing needs cohesive strategy to compete with China, says commission Feb

Is Mobic (Meloxicam) safe for an elderly patient with impaired renal function?

Translatome analysis also exposed that ABA, auxin and jasmonic acid (JA) biosynthesis, and signaling genes were activated during GSH treatment (Cheng et al

Thats why were dedicated to providing tailored solutions through compounded medication at a price that mimics the effects of GLP-1, helping to control appetite and encourage loss of mass